APPLAUD: A double-blinded, randomized, placebo-controlled, Phase 2 study of the efficacy and safety ofLAU-7B in the treatment of cystic fibrosis through correction of the AA/DHA imbalance

Project: Research project

Description

APPLAUD: A double-blinded, randomized, placebo-controlled, Phase 2 study of the efficacy and safety of LAU-7B in the treatment of cystic fibrosis through correction of the AA/DHA imbalance
StatusActive
Effective start/end date11/1/1811/1/20

Funding

  • LAURENT PHARMACEUTICALS INC

Fingerprint

Cystic Fibrosis
Placebos
Safety
Therapeutics